Frontlight ResearchEarly access
Osteoporosis trials in Netherlands
1 of 2 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
- Where
- Deventer, Geldrop, Maastricht, Zwolle
- Age
- 65 years to 91 years
- People
- 2,400 worldwide
- Run by
- AgNovos Healthcare, LLC
See details and how to joinNCT04796350